Skip to content

Clinical trials

Phase 2 Gastrointestinal Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Diseases Phase: Phase 2 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20051
20061
20093
20103
20121
20163
20173
20182
20201
20211
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status6
Terminated5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Facet Biotech2
Novartis2
Novartis Pharmaceuticals2
Adare Pharmaceuticals, Inc.1
Aduro Biotech, Inc.1
Arizona State University1
Bausch Health Americas, Inc.1
Bradley Connor1
Center for Rare Neurological Diseases, Norcross, GA1
CinDome Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Diseases28
Digestive System Diseases15
Intestinal Diseases10
Colonic Diseases7
Diarrhea6
Inflammatory Bowel Diseases6
Colitis4
Colitis, Ulcerative4
Digestive System Neoplasms4
Gastrointestinal Neoplasms4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.